Bipolar Disorder - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

Bipolar Disorder > What Your Doctor is Reading About Bipolar Disorder > Review Articles

Review Articles

1. Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence.

Author: Weisler RH; Calabrese JR; Bowden CL; Ascher JA; DeVeaugh-Geiss J; Evoniuk G;
Institution: University of North Carolina at Chapel Hill and Duke University Medical Center, United States. rweisler@aol.com
Journal: J Affect Disord. 2008 May;108(1-2):1-9. Epub 2007 Nov 14.
Abstract URL: Click here to view abstract

2. Olanzapine/fluoxetine combination for bipolar depression.

Author: Shelton RC;
Institution: Department of Psychiatry, Vanderbilt University Medical Center, Nashville, TN 37212, USA. richard.shelton@vanderbilt.edu
Journal: Expert Rev Neurother. 2006 Jan;6(1):33-9.
Abstract URL: Click here to view abstract

3. Bipolar disorder: historic perspective, current pharmacologic treatment options and a review of quetiapine.

Author: Khouzam HR; Singh F;
Institution: Chemical Dependency Treatment Program, Department of Psychiatry, VA Central California Healthcare System, Fresno, CA 93703-2286, USA. hani.khouzam2@.va.gov
Journal: Expert Rev Neurother. 2006 Feb;6(2):131-44.
Abstract URL: Click here to view abstract

4. What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?

Author: Severus WE; Kleindienst N; Seemuller F; Frangou S; Moller HJ; Greil W;
Institution: Department of Psychiatry, University of Munich, Munich, Germany. emanuel.severus@med.uni-muenchen.de
Journal: Bipolar Disord. 2008 Mar;10(2):231-7.
Abstract URL: Click here to view abstract

5. Efficacy of electroconvulsive therapy in the treatment of nondepressed psychiatric illness in elderly patients: a review of the literature.

Author: Wilkins KM; Ostroff R; Tampi RR; Wilkins KM; Ostroff R; Tampi RR;
Institution: Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA. kirsten.wilkins@yale.edu
Journal: J Geriatr Psychiatry Neurol. 2008 Mar;21(1):3-11.
Abstract URL: Click here to view abstract

6. Risperidone alone or in combination for acute mania.

Author: Rendell JM; Gijsman HJ; Bauer MS; Goodwin GM; Geddes GR;
Institution
Journal: Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004043.
Abstract URL: Click here to view abstract

7. Topiramate for acute affective episodes in bipolar disorder.

Author: Vasudev K; Macritchie K; Geddes J; Watson S; Young A;
Institution
Journal: Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003384.
Abstract URL: Click here to view abstract

8. Frontiers between attention deficit hyperactivity disorder and bipolar disorder.

Author: Galanter CA; Leibenluft E;
Institution: Division of Child and Adolescent Psychiatry, Columbia University/New York State Psychiatric Institute, 1051 Riverside Drive, #78, New York, NY 10032, USA. cg168@columbia.edu
Journal: Child Adolesc Psychiatr Clin N Am. 2008 Apr;17(2):325-46, viii-ix.
Abstract URL: Click here to view abstract

9. Emerging treatments for bipolar disorder: safety and adverse effect profiles.

Author: Marken PA; Pies RW;
Institution: Division of Pharmacy Practice, School of Pharmacy, University of Missouri--Kansas City, Kansas City, MO 64108-2792, USA. markenp@umkc.edu
Journal: Ann Pharmacother. 2006 Feb;40(2):276-85. Epub 2006 Jan 10.
Abstract URL: Click here to view abstract

10. Polytherapy in bipolar disorder.

Author: Lin D; Mok H; Yatham LN;
Institution: Department of Psychiatry, University of British Columbia, Vancouver, Canada.
Journal: CNS Drugs. 2006;20(1):29-42.
Abstract URL: Click here to view abstract

11. Pediatric bipolar disorder: emerging diagnostic and treatment approaches.

Author: Kowatch RA; DelBello MP;
Institution: Department of Psychiatry and Pediatrics, University of Cincinnati Medical Center & Cincinnati Children's Hospital Medical Center, MSB 7261, PO Box 670559, Cincinnati, OH 45267-0559, USA. robert.kowatch@uc.edu
Journal: Child Adolesc Psychiatr Clin N Am. 2006 Jan;15(1):73-108.
Abstract URL: Click here to view abstract

12. Ziprasidone: efficacy and safety in patients with bipolar disorder.

Author: Patel NC; Keck PE Jr;
Institution: University of Cincinnati, College of Pharmacy and Department of Psychiatry, College of Medicine, 3225 Eden Avenue, PO Box 670004, Cincinnati, OH 45267-0004, USA. nick.patel@uc.edu
Journal: Expert Rev Neurother. 2006 Aug;6(8):1129-38.
Abstract URL: Click here to view abstract

13. Lithium toxicity and the parturient: case report and literature review.

Author: Blake LD; Lucas DN; Aziz K; Castello-Cortes A; Robinson PN;
Institution: Department of Anaesthesia, Northwick Park Hospital, Harrow, UK.
Journal: Int J Obstet Anesth. 2008 Apr;17(2):164-9. Epub 2008 Mar 4.
Abstract URL: Click here to view abstract

14. Bipolar disorder--focus on bipolar II disorder and mixed depression.

Author: Benazzi F;
Institution: Hecker Psychiatry Research Center, Forli, Italy. francobenazzi@fbenazzi.it
Journal: Lancet. 2007 Mar 17;369(9565):935-45.
Abstract URL: Click here to view abstract

15. Clinical and neuropsychological characteristics of child and adolescent bipolar disorder.

Author: Kyte ZA; Carlson GA; Goodyer IM;
Institution: Developmental Psychiatry Section, University of Cambridge, UK. zak21@medschl.cam.ac.uk
Journal: Psychol Med. 2006 Sep;36(9):1197-211. Epub 2006 Mar 28.
Abstract URL: Click here to view abstract

16. Emerging drugs for bipolar disorder.

Author: Mitchell PB; Malhi GS;
Institution: School of Psychiatry, University of New South Wales, Black Dog Institute, Prince of Wales Hospital, Randwick, Sydney, NSW 2031, Australia. phil.mitchell@unsw.edu.au
Journal: Expert Opin Emerg Drugs. 2006 Nov;11(4):621-34.
Abstract URL: Click here to view abstract

17. Antipsychotic medications in the treatment of bipolar disorder.

Author: Surja AA; Tamas RL; El-Mallakh RS;
Institution: Mood Disorders Research Program, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA.
Journal: Curr Drug Targets. 2006 Sep;7(9):1217-24.
Abstract URL: Click here to view abstract

18. A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?

Author: Fountoulakis KN; Vieta E; Bouras C; Notaridis G; Giannakopoulos P; Kaprinis G; Akiskal H;
Institution: 3rd Department of Psychiatry, Aristotle University of Thessaloniki, Greece. kfount@med.auth.gr
Journal: Int J Neuropsychopharmacol. 2008 Mar;11(2):269-87. Epub 2007 May 17.
Abstract URL: Click here to view abstract

19. The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials.

Author: Weisler RH; Cutler AJ; Ballenger JC; Post RM; Ketter TA;
Institution: University of North Carolina at Chapel Hill, NC, USA. rweisler@aol.com
Journal: CNS Spectr. 2006 Oct;11(10):788-99.
Abstract URL: Click here to view abstract

20. The ascent into mania: a review of psychological processes associated with the development of manic symptoms.

Author: Mansell W; Pedley R;
Institution: School of Psychological Sciences, University of Manchester, UK. warren.mansell@manchester.ac.uk
Journal: Clin Psychol Rev. 2008 Mar;28(3):494-520. Epub 2007 Jul 27.
Abstract URL: Click here to view abstract

21. Predictors of relapse in bipolar disorder: A review.

Author: Altman S; Haeri S; Cohen LJ; Ten A; Barron E; Galynker II; Duhamel KN;
Institution: Albert Einstein College of Medicine, New York, NY, USA.
Journal: J Psychiatr Pract. 2006 Sep;12(5):269-82.
Abstract URL: Click here to view abstract

22. Mood disorders in the elderly.

Author: Gebretsadik M; Jayaprabhu S; Grossberg GT;
Institution: Department of Psychiatry, Saint Louis University School of Medicine, 1221 South Grand Boulevard, MO 63104, USA.
Journal: Med Clin North Am. 2006 Sep;90(5):789-805.
Abstract URL: Click here to view abstract

23. Associations between bipolar disorder and metabolic syndrome: A review.

Author: Taylor V; MacQueen G;
Institution: Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada. taylorv@mcmaster.ca
Journal: J Clin Psychiatry. 2006 Jul;67(7):1034-41.
Abstract URL: Click here to view abstract

24. Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials.

Author: Greenberg WM; Citrome L;
Institution: Department of Psychiatry, New York University School of Medicine, New York, NY, USA. wmg1019@optonline.net
Journal: CNS Drug Rev. 2007 Summer;13(2):137-77.
Abstract URL: Click here to view abstract

25. Oxcarbazepine in the treatment of bipolar and schizoaffective disorders.

Author: Popova E; Leighton C; Bernabarre A; Bernardo M; Vieta E;
Institution: Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain. katerina2663@yahoo.es
Journal: Expert Rev Neurother. 2007 Jun;7(6):617-26.
Abstract URL: Click here to view abstract

26. The armamentarium of treatments for bipolar disorder: a review of the literature.

Author: Cousins DA; Young AH;
Institution: Newcastle Magnetic Resonance Centre, Newcastle General Hospital, Westgate Road, Newcastle Upon Tyne, UK. D.A.Cousins@newcastle.ac.uk
Journal: Int J Neuropsychopharmacol. 2007 Jun;10(3):411-31. Epub 2006 Dec 19.
Abstract URL: Click here to view abstract

27. Olanzapine for the treatment of bipolar disorder in children and adolescents.

Author: Strawn JR; Delbello MP;
Institution: Department of Psychiatry, University of Cincinnati, Box 670559, Cincinnati, OH 45267-0559, USA. strawnjr@uc.edu
Journal: Expert Opin Pharmacother. 2008 Feb;9(3):467-74.
Abstract URL: Click here to view abstract

28. Neurobiology of bipolar disorder.

Author: Newberg AR; Catapano LA; Zarate CA; Manji HK;
Institution: National Institute of Mental Health, 10 Center Drive, MSC 1282, Building 10-CRC, Room 7-5545, Bethesda, MD 20892-1282, USA. newberga@mail.nih.gov
Journal: Expert Rev Neurother. 2008 Jan;8(1):93-110.
Abstract URL: Click here to view abstract

29. Gaps and limitations of psychological interventions for bipolar disorders.

Author: Scott J; Colom F;
Institution: University Department of Psychiatry, Royal Victoria Infirmary, Newcastle upon Tyne, UK. j.scott@iop.kcl.ac.uk
Journal: Psychother Psychosom. 2008;77(1):4-11. Epub 2007 Dec 14.
Abstract URL: Click here to view abstract

30. Continuous distribution of atypical depressive symptoms between major depressive and bipolar II disorders: dose-response relationship with bipolar family history.

Author: Akiskal HS; Benazzi F;
Institution: International Mood Center, University of California at San Diego, San Diego, CA, USA.
Journal: Psychopathology. 2008;41(1):39-42. Epub 2007 Oct 18.
Abstract URL: Click here to view abstract

31. Clinical inquiries. What's the best strategy for bipolar disorder during pregnancy?

Author: Minick G; Atlas M; Paladine H;
Institution: Guthrie Family Medicine Residency, Sayre, PA, USA.
Journal: J Fam Pract. 2007 Aug;56(8):665-8.

32. Early and accurate diagnosis of bipolar II disorder leads to successful outcomes.

Author: Cullen-Drill M; Cullen-Dolce D;
Institution: Columbia University School of Nursing, New York City, NY, USA. mcullendrill@aol.com
Journal: Perspect Psychiatr Care. 2008 Apr;44(2):110-9.
Abstract URL: Click here to view abstract

33. Folate and unipolar depression.

Author: Morris DW; Trivedi MH; Rush AJ;
Institution: Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-9119, USA. davidw.morris@utsouthwestern.edu
Journal: J Altern Complement Med. 2008 Apr;14(3):277-85.
Abstract URL: Click here to view abstract

34. Mood lability and bipolar disorder in children and adolescents.

Author: Miller L; Barnett S;
Institution: Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, USA. lmille84@jhmi.edu
Journal: Int Rev Psychiatry. 2008 Apr;20(2):171-6.
Abstract URL: Click here to view abstract

35. Omega-3 fatty acids for bipolar disorder.

Author: Montgomery P; Richardson AJ;
Institution: University of Oxford, Centre for Evidence-Based Intervention, Barnett House, 32 Wellington Square, Oxford, UK, OX1 2ER. paul.montgomery@socres.ox.ac.uk
Journal: Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005169.
Abstract URL: Click here to view abstract

36. The role of quetiapine in the treatment of bipolar disorder.

Author: Pini S; Abelli M; Cassano GB;
Institution: Department of Psychiatry, Neurobiology, Pharmacology and Biotechnology, University of Pisa, Via Roma 67, 56100 Pisa, Italy. s.pini@med.unipi.it
Journal: Expert Opin Pharmacother. 2006 May;7(7):929-40.
Abstract URL: Click here to view abstract

37. Managing bipolar disorder from urgent situations to maintenance therapy, part 2: focus on maintenance.

Author
Institution
Journal: J Clin Psychiatry. 2007 Aug;68(8):1290-300.

38. Pharmacotherapeutic strategies for pediatric bipolar disorder.

Author: Madaan V; Chang KD;
Institution: Creighton University/University of Nebraska Medical Center, Omaha, NE 68131, USA.
Journal: Expert Opin Pharmacother. 2007 Aug;8(12):1801-19.
Abstract URL: Click here to view abstract

39. Does bipolar disorder exist in children? A selected review.

Author: Duffy A;
Institution: Department of Psychiatry, McGill University, Montreal Children's Hospital, Quebec, Canada. anne.duffy@mcgill.ca
Journal: Can J Psychiatry. 2007 Jul;52(7):409-17.
Abstract URL: Click here to view abstract

40. Maintenance treatment in bipolar disorder: a focus on aripiprazole.

Author: McIntyre RS; Woldeyohannes HO; Yasgur BS; Soczynska JK; Miranda A; Konarski JZ;
Institution: University of Toronto, Department of Psychiatry, Department of Pharmacology, Toronto, ON, Canada. roger.mcintyre@uhn.on.ca
Journal: Expert Rev Neurother. 2007 Aug;7(8):919-25.
Abstract URL: Click here to view abstract

41. Historical review of carbamazepine for the treatment of bipolar disorder.

Author: Stoner SC; Nelson LA; Lea JW; Marken PA; Sommi RW; Dahmen MM;
Institution: School of Pharmacy, University of Missouri, Kansas City, Missouri, USA. stoners@umkc.edu
Journal: Pharmacotherapy. 2007 Jan;27(1):68-88.
Abstract URL: Click here to view abstract

42. Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice.

Author: Post RM; Ketter TA; Uhde T; Ballenger JC;
Institution: Bipolar Collaborative Network, Chevy Chase, Maryland, USA.
Journal: CNS Drugs. 2007;21(1):47-71.
Abstract URL: Click here to view abstract

43. Adaptive strategies for treating childhood mania.

Author: Dawson R; Lavori PW; Luby JL; Ryan ND; Geller B;
Institution: Frontier Science Technology and Research Foundation, Boston, Massachusetts 02215, USA. Dawson@fstrf.dfci.harvard.edu
Journal: Biol Psychiatry. 2007 Mar 15;61(6):758-64. Epub 2006 Dec 12.
Abstract URL: Click here to view abstract

44. Zonisamide for bipolar depression.

Author: Wilson MS; Findling RL;
Institution: Case Western Reserve University/University Hospitals Case Medical Center, Division of Child & Adolescent Psychiatry, Department of Psychiatry, 11100 Euclid Ave, Cleveland, OH 44106-5080, USA.
Journal: Expert Opin Pharmacother. 2007 Jan;8(1):111-3.
Abstract URL: Click here to view abstract

45. Bipolar depression: a review of randomised clinical trials.

Author: Goodnick PJ;
Institution: Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Carrier Clinic, POB 147, 252 CR 601, Belle Mead, NJ 08502, USA. pgoodnick@aol.com
Journal: Expert Opin Pharmacother. 2007 Jan;8(1):13-21.
Abstract URL: Click here to view abstract

46. New findings from the Bipolar Collaborative Network: clinical implications for therapeutics.

Author: Post RM; Altshuler LL; Frye MA; Suppes T; McElroy S; Keck PE Jr; Leverich GS; Kupka R; Nolen WA; Grunze H;
Institution: Penn State College of Medicine, Hershey, PA, USA. robert.post@speakeasy.net
Journal: Curr Psychiatry Rep. 2006 Dec;8(6):489-97.
Abstract URL: Click here to view abstract

47. Bipolar II disorder: current and future treatment options.

Author: El-Mallakh R; Weisler RH; Townsend MH; Ginsberg LD;
Institution: Dept. of Psychiatry, University of Louisville School of Medicine, Louisville, KY 40202, USA. rselma01@louisville.edu
Journal: Ann Clin Psychiatry. 2006 Oct-Dec;18(4):259-66.
Abstract URL: Click here to view abstract

48. Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials.

Author: Singh JB; Zarate CA Jr;
Institution: Mood and Anxiety Disorders Research Program, National Institute of Mental Health, 10 Center Drive, Bethesda, MD 20892, USA.
Journal: Bipolar Disord. 2006 Dec;8(6):696-709.
Abstract URL: Click here to view abstract

49. Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy.

Author: Smith LA; Cornelius V; Warnock A; Tacchi MJ; Taylor D;
Institution: Medical Research Matters, Eynsham, UK.
Journal: Acta Psychiatr Scand. 2007 Jan;115(1):12-20.
Abstract URL: Click here to view abstract

50. Oxcarbazepine in bipolar disorder: a critical review of the literature.

Author: Mazza M; Di Nicola M; Martinotti G; Taranto C; Pozzi G; Conte G; Janiri L; Bria P; Mazza S;
Institution: Institute of Psychiatry, Bipolar Disorders Unit, Catholic University of Sacred Heart, Rome, Italy. mariannamazza@hotmail.com
Journal: Expert Opin Pharmacother. 2007 Apr;8(5):649-56.
Abstract URL: Click here to view abstract

51. Evolving trends in the long-term treatment of bipolar disorder.

Author: Vieta E; Rosa AR;
Institution: Bipolar Disorders Program, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain. evieta@clinic.ub.es
Journal: World J Biol Psychiatry. 2007;8(1):4-11.
Abstract URL: Click here to view abstract

52. Prevention of pediatric bipolar disorder: integration of neurobiological and psychosocial processes.

Author: Chang K; Howe M; Gallelli K; Miklowitz D;
Institution: Pediatric Bipolar Disorders Program, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA. kchang88@stanford.edu
Journal: Ann N Y Acad Sci. 2006 Dec;1094:235-47.
Abstract URL: Click here to view abstract

53. Pharmacological treatment of bipolar disorder among children and adolescents.

Author: Blader JC; Kafantaris V;
Institution: Stony Brook State University of New York, NY, USA. joseph.blader@stonybrook.edu
Journal: Expert Rev Neurother. 2007 Mar;7(3):259-70.
Abstract URL: Click here to view abstract

54. Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?

Author: Clayton AH;
Institution: Department of Psychiatry and Neurobehavioural Sciences, University of Virginia, 2955 Ivy Road, Northridge Suite 210, Charlottesville, VA 22903, USA. ahc8v@virginia.edu
Journal: Expert Opin Pharmacother. 2007 Mar;8(4):457-66.
Abstract URL: Click here to view abstract

55. Treatments for late-life bipolar disorder.

Author: Aziz R; Lorberg B; Tampi RR;
Institution: Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Journal: Am J Geriatr Pharmacother. 2006 Dec;4(4):347-64.
Abstract URL: Click here to view abstract

56. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.

Author: Hamrin V; Pachler M;
Institution: Yale University School of Nursing, New Haven, USA. vanya.hamrin@yale.edu
Journal: J Child Adolesc Psychiatr Nurs. 2007 Feb;20(1):40-58.
Abstract URL: Click here to view abstract

57. Bipolar (spectrum) disorder and mood stabilization: standing at the crossroads?

Author: De Fruyt J; Demyttenaere K;
Institution: Department of Psychiatry, General Hospital Sint-Jan AV, Brugge, Belgium. jurgen.defruyt@azbrugge.be
Journal: Psychother Psychosom. 2007;76(2):77-88.
Abstract URL: Click here to view abstract

58. Extrapyramidal adverse events associated with atypical antipsychotic treatment of bipolar disorder.

Author: Gentile S;
Institution: Department of Mental Health ASL Salerno 1, Mental Health Center, Italy. salvatore_gentile@alice.it
Journal: J Clin Psychopharmacol. 2007 Feb;27(1):35-45.
Abstract URL: Click here to view abstract

59. Collaborative management of women with bipolar disorder during pregnancy and postpartum: pharmacologic considerations.

Author: Ward S; Wisner KL;
Institution: Department of Obstetrics, Gynecology & Women's Health, University of Louisville School of Medicine, Louisville, KY 40292, USA. sward@louisville.edu
Journal: J Midwifery Womens Health. 2007 Jan-Feb;52(1):3-13.
Abstract URL: Click here to view abstract

60. Comorbidity of eating disorders with bipolar disorder and treatment implications.

Author: McElroy SL; Kotwal R; Keck PE Jr;
Institution: Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA. susan.mcelroy@uc.edu
Journal: Bipolar Disord. 2006 Dec;8(6):686-95.
Abstract URL: Click here to view abstract

61. Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations.

Author: Frye MA; Salloum IM;
Institution: Department of Psychiatry and Biobehavioral Sciences, Geffen School of Medicine at UCLA, University of California-Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA, USA. mfrye@mayo.edu
Journal: Bipolar Disord. 2006 Dec;8(6):677-85.
Abstract URL: Click here to view abstract

62. Anxiety disorders and bipolar disorder: a review.

Author: McIntyre RS; Soczynska JK; Bottas A; Bordbar K; Konarski JZ; Kennedy SH;
Institution: Department of Psychiatry and Pharmacology, University Health Network, University of Toronto, 399 Bathurst Street, Toronto, Ontario, Canada. roger.mcintyre@uhn.on.ca
Journal: Bipolar Disord. 2006 Dec;8(6):665-76.
Abstract URL: Click here to view abstract

63. Atypical antipsychotics in the treatment of mood disorders.

Author: Jarema M;
Institution: III Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland. Jarema@ipin.edu.pl
Journal: Curr Opin Psychiatry. 2007 Jan;20(1):23-9.
Abstract URL: Click here to view abstract

64. Bipolar disorder: improving diagnosis and optimizing integrated care.

Author: Culver JL; Arnow BA; Ketter TA;
Institution: Stanford University, Department of Psychiatry and Behavioral Sciences, Stanford, CA 94305, USA. jculver@stanford.edu
Journal: J Clin Psychol. 2007 Jan;63(1):73-92.
Abstract URL: Click here to view abstract

65. Emerging therapies for bipolar depression.

Author
Institution
Journal: J Clin Psychiatry. 2006 Jul;67(7):1140-51.

66. Psychosocial strategies to improve concordance and adherence in bipolar disorder.

Author: Reilly-Harrington N; Sachs GS;
Institution: Bipolar Clinic and Research Program, Massachusetts General Hospital and Harvard Medical School, Boston, USA.
Journal: J Clin Psychiatry. 2006 Jul;67(7):e04.
Abstract URL: Click here to view abstract

67. Acute treatment of mania: an update on new medications.

Author: Gajwani P; Kemp DE; Muzina DJ; Xia G; Gao K; Calabrese JR;
Institution: Case School of Medicine, Mood Disorders Program, University Hospitals Case Medical Center, 11400 Euclid Avenue, Suite 200, Cleveland, OH 44106, USA. Prashant.Gajwani@uhhs.com
Journal: Curr Psychiatry Rep. 2006 Dec;8(6):504-9.
Abstract URL: Click here to view abstract

68. An update on the role of psychotherapy in the management of bipolar disorder.

Author: Miklowitz DJ;
Institution: Department of Psychology, Muenzinger Building, University of Colorado, Boulder, CO 80309-0345, USA. miklowitz@colorado.edu
Journal: Curr Psychiatry Rep. 2006 Dec;8(6):498-503.
Abstract URL: Click here to view abstract

69. Pharmacotherapy of bipolar depression: an update.

Author: Thase ME;
Institution: University of Pittsburgh Medical Center, Western Psychiatric Institute and Clinic, 3811 O'Hara St., Pittsburgh, PA 15213-2593, USA. thaseme@upmc.edu
Journal: Curr Psychiatry Rep. 2006 Dec;8(6):478-88.
Abstract URL: Click here to view abstract